Exelixis Inc at Bank of America Healthcare Conference Transcript
Thank you for joining us at the BofA Annual Healthcare Conference. My name is Jason Gerberry. I'm one of the biotech analyst at Bank of America, and I'm pleased to be introducing our next company presenter, Exelixis' CEO, Mike Morrissey. So Mike, thanks for joining us.
Great to be here. It's been a long time since we've done this live. So good to see you.
Yes. Of course. So coming fresh off the print 1Q results, which seems your volume growth on cabo really impressive Q-over-Q growth. It seems like you're getting the benefit of some patient stacking in the new frontline RCC indication. So things are going well there. You've got patent trial. You've got a lot of pipeline coming to the surface in the second half of the year, that was earlier stage. We're going to have some data to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
